Lightcalls.com
 

For religious or for bad, we are e...

Bill Of Sale
Air Miles
Award Winning Linux Data Recovery Software from Disk Doctors

For religious or for bad, we are entering a recent age in medicinal plant research. More and more, we view greater usage of the recently made known buzz word "phytochemicals." This involves looking for benefits in isolated specific chemicals within plants instead of in whole plants, and parallels the shift from one reliance on whole vegetables and fruits and other pabulums toward supplementation with vitamins and minerals.

Talk of as it is phytochemicals as procyanidins, flavonoids, antioxidants, carotene, etc has replaced discussion of vitamin A and zinc. on the contrary we still want it all in a little capsule-size package. This modern movement may be just a natural progression in nutritional evolution. At the remarkably least, proper implementation of fresh research findings will demand a great extent of sophistication on the part of herb manufacturers and interest onward the part of the consumer

Making practical sensation of the science of phytochemistry



Of course, research onward individual plant chemicals is not new; it is just that we are feeling a greater ne to make practical faculty of perception of it. Typically, such research is compact and requires an extensive education in biochemistry, physiology, pharmacology, medicine, and biophysics to understand it. To make the thought more approachable, we look for biomedical gauges that can be used to exhibit to the benefits of individual medicinal agents. united such model is experimentally-induced skin cancer. Let's use this as an example of to what degree we might go about the proces of understanding the science of phytochemistry.

The sequential degrees in the formation of skin cancer include the initiation of the tumor, the promotion or propagation of the tumor, and the progression of the tumor. Typically, the mutational consequences of tumor initiation are irreversible, to such a degree one basic approach to skin tumor prevention is to identify naturally-occurring substances that can inhibit the reversible propagation stage. We start by means of obtaining a substance, say TPA (12-0-tetradecanoylphorbal 13 acetate), that is known to cause changes in the skin that lead to tumor propagation, changes like initiation of activity of ODC (ornithine decarboxylase), stimulation of Hpx (hydroperoxide) production, and an increase in DNA production.

nearest researchers identify plant substances that they suspect stiffen those events induced by TPA. at short intervals selected materials are polyphenolic materials, notably tannins. which are widely distributed in the plant kingdom: gallotannins, ellagitannins, proanthocyanidins, or procyanidins.

Ellagic acid and gallotannins decrease mutation, tumor initiation, and entire carcinogenesis, and, not surprisingly, debar the biochemical events of TPA, therefore showing athletic antitumor-promoting activities in the experimental example as applied to the skin in living mice (the TPA example is painless and harmless and is, therefore, a suitable standard for living organisms).

Procyanidins from blooming tea have anti-cancer abilities

Likewise, procyanidins extracted from blooming tea possess anti-mutagenic and anticarcinogenic activity, and inhibit tumor initiation and promotion in the skin and other organs. Oligomeric tannins from burgout pine, and several flavonoids (catechins and epicatechins) also significantly shape the effects of TPA application to mouse skin.

As research progresse all kinds of seemingly insignificant details are discovered, if it be not that which may ultimately prove to be of inestimable value in assessing the benefits of various plant materials.

Another finding to issue from this line of research is that the anti-cancer action of tannins is paralleled from their antioxidative activity.

It is hinted that these substances interfere with molecular pathways regulating enzyme activities; they have a high reducing (opposite of oxidizing) power and form complexe with about metal ions and cofactors that are required in the generation of unrestrained radicals that cause the cancer. Or they may act simply by dint of increasing the nonspecific immune answer of the body, or both

As data like these continue to accumulate about the mechanisms of action of all the classes of phytochemicals, it will provide more, and more, of the science base from which we can make our dietary-supplementation decisions.

COPYRIGHT 1997 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.